185 related articles for article (PubMed ID: 19862340)
41. Overexpression of angiogenin in pterygium body fibroblasts and its association with proliferative potency.
Kim KW; Park SH; Wee SW; Kim JC
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6355-62. PubMed ID: 23989187
[TBL] [Abstract][Full Text] [Related]
42. Over-expression of human cystatin C in pterygium versus healthy conjunctiva.
Barba-Gallardo LF; Ventura-Juárez J; Kershenobich Stalnikowitz D; Gutiérrez-Campos R; Torres-Bernal E; Torres-Bernal LF
BMC Ophthalmol; 2013 Feb; 13():6. PubMed ID: 23442876
[TBL] [Abstract][Full Text] [Related]
43. Overexpression of p53 tumor suppressor gene in pterygia.
Weinstein O; Rosenthal G; Zirkin H; Monos T; Lifshitz T; Argov S
Eye (Lond); 2002 Sep; 16(5):619-21. PubMed ID: 12194078
[TBL] [Abstract][Full Text] [Related]
44. 4-Hydroxyhexenal- and 4-hydroxynonenal-modified proteins in pterygia.
Sano I; Kaidzu S; Tanito M; Hara K; Okuno T; Ohira A
Oxid Med Cell Longev; 2013; 2013():602029. PubMed ID: 23766855
[TBL] [Abstract][Full Text] [Related]
45. Expression analysis of human pterygium shows a predominance of conjunctival and limbal markers and genes associated with cell migration.
Jaworski CJ; Aryankalayil-John M; Campos MM; Fariss RN; Rowsey J; Agarwalla N; Reid TW; Dushku N; Cox CA; Carper D; Wistow G
Mol Vis; 2009 Nov; 15():2421-34. PubMed ID: 19956562
[TBL] [Abstract][Full Text] [Related]
46. Elastin development-associated extracellular matrix constituents of subepithelial connective tissue in human pterygium.
Pérez-Rico C; Pascual G; Sotomayor S; Asúnsolo Á; Cifuentes A; García-Honduvilla N; Buján J
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6309-18. PubMed ID: 25183766
[TBL] [Abstract][Full Text] [Related]
47. [The abnormal expression of interleukine-1 family in pterygium].
Wen Z; Liu Z
Yan Ke Xue Bao; 2003 Jun; 19(2):133-6. PubMed ID: 12870354
[TBL] [Abstract][Full Text] [Related]
48. Conjunctival Expression of Toll-Like Receptor 3 Plays a Pathogenic Role in the Formation of Ultraviolet Light-Induced Pterygium.
Lai CC; Tseng SH; Hsu SM; Huang YT; Shieh CC
Invest Ophthalmol Vis Sci; 2021 Aug; 62(10):6. PubMed ID: 34369985
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical study of p53, p21 and PCNA in pterygium.
Ueda Y; Kanazawa S; Kitaoka T; Dake Y; Ohira A; Ouertani AM; Amemiya T
Acta Histochem; 2001 Apr; 103(2):159-65. PubMed ID: 11368097
[TBL] [Abstract][Full Text] [Related]
50. YKL-40 expression in pterygium: a potential role in the pathogenesis.
Kurt A; Kılıç R; Tad M; Polat OA
Int Ophthalmol; 2019 Jul; 39(7):1445-1450. PubMed ID: 29922975
[TBL] [Abstract][Full Text] [Related]
51. Expression of stem cell factor in pterygium.
Nakagami T; Watanabe I; Murakami A; Okisaka S; Ebihara N
Jpn J Ophthalmol; 2000; 44(3):193-7. PubMed ID: 10913635
[TBL] [Abstract][Full Text] [Related]
52. [The abnormal expression of epidermal growth factor receptor family in pterygium].
Liu Z; Xie Y; Zhang M; Pflugfelder SC
Zhonghua Yan Ke Za Zhi; 2000 Sep; 36(5):372-4, 25. PubMed ID: 11853633
[TBL] [Abstract][Full Text] [Related]
53. A novel approach to investigation of the pathogenesis of pterygium based on assessment of promoter hyper-methylation and expression profile of CTLA4 gene: A credible report of CTLA4 gene expression in human eye tissue.
Ebrahimi ME; Kordi-Tamandani DM; Arish M
Gene; 2016 Jun; 583(2):130-133. PubMed ID: 26899867
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of epithelial cell proliferating activity and fibroblast nuclear kariometry in recurrent pterygium treated with mitomycin C.
Almeida Junior GC; Frederico FB; Watanabe KP; Garcia TV; Iquejiri AY; Cury PM; Taboga SR; Azoubel R
Arq Bras Oftalmol; 2008; 71(4):568-75. PubMed ID: 18797670
[TBL] [Abstract][Full Text] [Related]
55. Nestin expression in pterygia: potential role in angiogenesis.
Tonthat CV; Di Girolamo N
Br J Ophthalmol; 2014 Jun; 98(6):801-7. PubMed ID: 24008823
[TBL] [Abstract][Full Text] [Related]
56. Increased Expression of Aquaporin-1 and Aquaporin-3 in Pterygium.
Ortak H; Cayli S; Ocakli S; Demir S
Cornea; 2013 Oct; 32(10):1375-9. PubMed ID: 23974882
[TBL] [Abstract][Full Text] [Related]
57. Regulation of vascular endothelial growth factor-C by tumor necrosis factor-α in the conjunctiva and pterygium.
Dong Y; Kase S; Dong Z; Fukuhara J; Tagawa Y; Ishizuka ET; Murata M; Shinmei Y; Ohguchi T; Kanda A; Noda K; Ishida S
Int J Mol Med; 2016 Aug; 38(2):545-50. PubMed ID: 27314284
[TBL] [Abstract][Full Text] [Related]
58. HIF1α and HIF2α immunoreactivity in epithelial tissue of primary and recurrent pterygium by immunohistochemical analysis.
Schoelles KJ; Kemper K; Martin G; Boehringer D; Brinks K; Mittelviefhaus H; Reinhard T; Auw-Haedrich C
Int Ophthalmol; 2023 Dec; 43(12):4551-4562. PubMed ID: 37684398
[TBL] [Abstract][Full Text] [Related]
59. Alteration of sialyl Lewis epitope expression in pterygium.
Creuzot-Garcher C; Guerzider V; Assem M; Bron AM; Delannoy P; Bara J
Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1631-6. PubMed ID: 10393028
[TBL] [Abstract][Full Text] [Related]
60. P53 expression in altered limbal basal cells of pingueculae, pterygia, and limbal tumors.
Dushku N; Reid TW
Curr Eye Res; 1997 Dec; 16(12):1179-92. PubMed ID: 9426949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
